Evaluation of the Temperature Difference of Medical Gases Between the Heated Inspiratory Limb and the Tracheal Carina in Patients Undergoing Invasive Mechanical Ventilation With Active Humidification: A Crossover Clinical Study.

November 13, 2026 updated by: Riccardo Re, Azienda Sanitaria Universitaria Integrata del Trentino

The aim of this study is to assess the actual temperature drop of medical gases from the distal end of the heated ventilator circuit to the tracheal carina during invasive mechanical ventilation with active humidification. This analysis reflects the investigators' intention to observe the temperature drop under real-world clinical practice conditions, while assessing potential interactions with patient body temperature, ambient temperature, and the size of unheated ventilatory connectors. These findings may provide insight into the appropriate temperature and humidity targets, thereby further optimizing active humidification during invasive mechanical ventilation.

Study Overview

Detailed Description

Study setting: Patients undergoing invasive mechanical ventilation via orotracheal tube, nasotracheal tube, or tracheostomy cannula.

Research Hypothesis: The temperature drop between the distal end of the heated inspiratory circuit and the distal end of the tracheal tube does not exceed 2°C; therefore, heating medical gases above 37°C is not necessary.

Study Objective: 1) To assess the temperature difference between the distal end of the heated inspiratory limb and the patient's tracheal carina. 2) To identify variables that may influence the temperature drop, including connector size (dead space), the presence of a mainstream end-tidal CO₂ sensor, type, dimension and depth of tracheal tube (orotracheal, nasotracheal, tracheostomy), ventilation mode and minute volume, patient body temperature, and ambient temperature.

Study Design: Crossover clincal study Inclusion Criteria: Adult patients admitted to the Intensive Care Unit 1 of Santa Chiara Hospital in Trento, who are receiving invasive mechanical ventilation with active humidification via a tracheal tube and who already have invasive body temperature monitoring in place.

Exclusion Criteria: Patients ventilated with tracheal tubes smaller than size 7 or patients ventilated using double-lumen tubes for selective bronchial intubation.

Protocol: The study protocol involves measuring, in all patients meeting the inclusion criteria, the temperature at the end of the heated ventilator circuit ("Tpatient") and the air temperature at the level of the tracheal carina. Tpatient will be recorded as the direct reading from the humidifier display. Tracheal temperature will be measured by inserting a sterile temperature probe through the ventilator circuit. To obtain an accurate measurement of air temperature without the probe contacting the tracheal mucosa, a graduated probe will be used, calibrated according to the correct insertion depth corresponding to the tracheal tube in use. The temperature recorded by the probe will then be displayed via a dedicated electrical cable on the bedside multiparameter monitor. The heat humidifier used in the study will be the device currently available in ICU 1 of Santa Chiara Hospital in Trento, namely the Dräger Aquapor H300® humidifier. The device will be set in FREE mode, allowing the investigators to freely adjust temperature settings according to the study protocol. For each enrolled patient, two sets of measurements will be performed using different humidification settings. The first set will use a Tpatient of 37°C with a -2°C gradient (Tpatient 37°C - chamber temperature 35°C), while the second set will use a Tpatient of 40°C with a -3°C gradient (Tpatient 40°C - chamber temperature 37°C). The order in which the first or second measurement set is performed will be randomly assigned using a web-based randomization tool (random.org). Before temperature measurements are performed, correct attainment of the target humidifier temperature will be verified. For each observation, the following variables will also be recorded: age and male patient core body temperature, type of airway device, tube size, depth of tube placement, volume of unheated connectors, presence of a mainstream end-tidal CO₂ sensor, ventilation mode, minute ventilation at the time of measurement, and ambient temperature. At the end of the measurements, the probe will be removed and placed on the patient's pillow to measure the ambient temperature in the immediate vicinity of the patient.

Timeframe: The study aims to enroll 50 patients within a maximum period of one year from the first measurement.

Statistical Analysis: During the statistical analysis, the mean, standard deviation, median, and range of the temperature differences between Tpatient and the air temperature at the tracheal carina will be calculated for the two humidification settings (37°C and 40°C). These values will then be compared using the Bland-Altman method. In addition, potential correlations between temperature variations and the study's objective variables will be analysed, including core body temperature, type and size of the airway device, depth of tube placement, volume of unheated connectors, presence of a mainstream end-tidal CO₂ sensor, minute ventilation at the time of measurement, and ambient temperature.

Expected Results: The temperature drop induced by unheated ventilator connectors (catheter mount and tracheal tube/cannula) does not exceed 2°C and is influenced by both ambient temperature and patient body temperature. Accordingly, a heated inspiratory circuit temperature setting above 37°C is not necessary.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Italy
      • Trento, Italy, Italy, 38100
        • Recruiting
        • Santa Chiara Hospital of Trento - ASUIT
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: Adult patients admitted to the Intensive Care Unit 1 of Santa Chiara Hospital in Trento, who are receiving invasive mechanical ventilation with active humidification via a tracheal tube and who already have invasive body temperature monitoring in place.

Exclusion Criteria: Patients ventilated with tracheal tubes smaller than size 7 or patients ventilated using double-lumen tubes for selective bronchial intubation

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Temperature drop 37°C

Measure of the temperarure drop in two different humidification setting: 37°C - 40°C

Evaluation of the temperature drop from the end of the heated ventilatory tube to the tracheal carina

Experimental: Temperature drop 40°C

Evaluation of the temperature drop from the end of the heated ventilatory tube to the tracheal carina

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Temperature drop
Time Frame: 50 patients or 1 year

Measure the real temperature drop from the end of the heated respiratory tube and the tracheal carina in the patient with mechanical invasive ventilation and active humidification.

50 patients or 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 22, 2026

Primary Completion (Estimated)

June 22, 2027

Study Completion (Estimated)

June 22, 2027

Study Registration Dates

First Submitted

November 13, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 18, 2026

Study Record Updates

Last Update Posted (Actual)

November 18, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • CARINA TEMP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe